- Academic Registry
Course & Unit Catalogues


SL50168: Advances in molecular medicine (BB50245)

[Page last updated: 26 October 2023]

Academic Year: 2023/24
Owning Department/School: Department of Life Sciences
Credits: 20 [equivalent to 40 CATS credits]
Notional Study Hours: 400
Level: Masters UG & PG (FHEQ level 7)
Period:
Academic Year
Assessment Summary: CW 50%, EX 40%, OT 10%
Assessment Detail:
  • Online Tests on Core Knowledge (OT 10%)
  • Research Paper Seminar Presentation (CW 20%)
  • Literature Review (2000-3000 words) (CW 30%)
  • Synoptic Written Examination (EX 40%)
Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Requisites:
Learning Outcomes: By the end of this unit you will be able to:
* Apply your understanding of your core molecular medicine knowledge drawing on concepts in the molecular and cellular basis of disease
* Critically evaluate and communicate the findings of a cutting-edge molecular medicine research publication through a formal presentation
* Critically evaluate, synthesise and summarise the findings of a variety of cutting-edge molecular medicine research publications through a written literature review
* Demonstrate an integrative and evaluative approach to addressing some of the challenges and opportunities in treating human diseases.


Aims: The unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease.

Content: This unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease. Topics will include:
* molecular genetics/epigenetics of cancer, diabetes, stem cell reprogramming, medical neuroscience, immunology and epidemiology of infections.
* Molecular approaches used to develop interventions (genomics for vaccine and chemotherapeutic target identification, Next Generation Sequencing, epidemiology and prediction, regenerative medicine, personalised medicine).

Course availability:

SL50168 is a Designated Essential Unit on the following courses:

Department of Life Sciences
  • RSSL-AFM09 : Integrated PhD Molecular Biosciences (Medical Biosciences)
  • TSSL-AFM03 : MSc Molecular Biosciences (Medical Biosciences)
  • TSSL-AWM03 : MSc Molecular Biosciences (Medical Biosciences)

Notes:

  • This unit catalogue is applicable for the 2023/24 academic year only. Students continuing their studies into 2024/25 and beyond should not assume that this unit will be available in future years in the format displayed here for 2023/24.
  • Courses and units are subject to change in accordance with normal University procedures.
  • Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.
  • Find out more about these and other important University terms and conditions here.